HIV Antibody Oral Mucosal Transudate Self-Testing Kit Obtains Medical Device Registration Certificate
December 26, 2025
Source: drugdu
30
People's Finance News, December 25 – Wantai Biotech (603392) announced on December 25 that its self-developed HIV (Type 1+2) Antibody Oral Mucosal Transudate Testing Kit (Colloidal Gold Method) has obtained the "Medical Device Registration Certificate (In Vitro Diagnostic Reagent)" issued by the National Medical Products Administration (NMPA). Additionally, the clinical trial application for the "Recombinant Trivalent Rotavirus Subunit Vaccine (Escherichia coli)", submitted by its wholly-owned subsidiary Xiamen Wantai Kangtai Biotech Co., Ltd., has been accepted for review by the NMPA.
Reference：https://finance.eastmoney.com/a/202512253601917149.html
By editor
Copyright©2025 Ddu. All rights reserved.
Read more on
- Innovative Drug KarXT® (Karigel®) Approved in China December 26, 2025
- Xueji Biotech Completes Over RMB 100 Million Initial Close of Series B1 Equity Funding and Over RMB 100 Million in Debt Funding December 26, 2025
- Just 1 minute! Roche’s bispecific antibody subcutaneous injection formulation receives FDA approval for market launch December 26, 2025
- Pfizer loses out in hemophilia December 26, 2025
- Maiwei Biotech’s new monoclonal antibody drug has received FDA approval to begin Phase 2a clinical trials for COPD December 26, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
